CytomX Therapeutics
151 Oyster Point Boulevard,
San Francisco, 94080, CA,
United States
San Francisco, 94080, CA,
United States
1 650-326-9400
Life Sciences
CytomX Therapeutics Technographics
CytomX Therapeutics Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by CytomX Therapeutics and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 174 CytomX Therapeutics employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that CytomX Therapeutics has purchased the following applications: Oracle NetSuite ERP for ERP Financial in 2014, Microsoft 365 for Collaboration in 2015, Agiloft Contract Lifecycle Management for Contract Lifecycle Management in 2018 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems CytomX Therapeutics is running and its propensity to invest more and deepen its relationship with Oracle , Microsoft , Agiloft or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing CytomX Therapeutics revenues, which have grown to $69.6 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for CytomX Therapeutics intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
CytomX Therapeutics Tech Stack and Enterprise Applications
CytomX Therapeutics ERP
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Oracle | Legacy | Oracle NetSuite ERP | ERP Financial | ERP | n/a | 2014 | 2014 |
In 2014, CytomX Therapeutics implemented Oracle NetSuite ERP. Oracle NetSuite ERP was deployed to address ERP Financial functions, consolidating finance and accounting workflows under a single cloud system. The deployment emphasized central financial management capabilities typical for the ERP Financial category.
The implementation was configured to provide standard ERP Financial capabilities including general ledger, accounts payable, accounts receivable, billing, fixed asset accounting and revenue management to support CytomX Therapeutics finance operations. The solution leveraged NetSuite's cloud hosted architecture to centralize the chart of accounts and standardize month end close and financial reporting processes across the finance and accounting teams. Governance focused on finance process standardization and system driven transaction flows to improve consistency and control of financial records.
|
CytomX Therapeutics Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2015 | 2015 |
In 2015, CytomX Therapeutics began using Microsoft 365 as its primary Collaboration platform, a usage that is visible on the company website. The Microsoft 365 application is deployed as a cloud-hosted, tenant-based Collaboration environment delivering standard collaboration capabilities, including hosted email and calendaring, document co-authoring and centralized content libraries, and team chat and meetings consistent with Microsoft 365 functional scope.
The Microsoft 365 Collaboration footprint for CytomX Therapeutics aligns with the operational needs of a 174 employee life sciences organization, supporting R&D administrative workflows, research support functions, and corporate communications. Governance is consistent with a centralized tenant model, using role-based access and document sharing policies and standard cloud collaboration controls, and the public site usage indicates corporate adoption of Microsoft 365 services for both internal collaboration and external presence.
|
CytomX Therapeutics Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Agiloft | Legacy | Agiloft Contract Lifecycle Management | Contract Lifecycle Management | Content Management | n/a | 2018 | 2018 |
In 2018, CytomX Therapeutics implemented Agiloft Contract Lifecycle Management as its centralized contract platform. The deployment positioned Agiloft Contract Lifecycle Management to serve core business functions including legal and commercial contracting, supplier agreements, and deal governance within the organization.
The implementation emphasized standard Contract Lifecycle Management capabilities, including a centralized contract repository, template and clause libraries, configurable approval routing, automated workflow orchestration for authoring and review, and search and reporting functionality. Configuration work focused on template standardization, role based access controls, and automated notifications to enforce review cycles and approval SLAs consistent with CLM best practices.
Operational coverage extended to legal and commercial teams and was governed through a designated administrative model that controlled templates, clause reuse, and workflow change management. The program documented policy driven workflows and instituted training for contract administrators and business users to ensure consistent use of the Agiloft Contract Lifecycle Management system across the organization.
|
|
|
|
|
Digital Signing | Content Management |
|
2021 | 2021 |
|
CytomX Therapeutics CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Customer Experience | CRM |
|
2019 | 2019 |
|
|
|
|
|
Customer Support | CRM |
|
2019 | 2019 |
|
CytomX Therapeutics IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2014 | 2014 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
CytomX Therapeutics CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Identity and Access Management (IAM) | CyberSecurity |
|
2021 | 2021 |
|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2017 | 2017 |
|
IT Decision Makers and Key Stakeholders at CytomX Therapeutics
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
|
|
Vice President, Business Development and Alliance Management | VP | Sales | |
|
|
|
Chief Executive Officer | CXO | Finance | |
|
|
|
CFO | CXO | Finance | |
|
Apps Being Evaluated by CytomX Therapeutics Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from CytomX Therapeutics IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the CytomX Therapeutics digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD CytomX Therapeutics Technographics
CytomX Therapeutics is a Life Sciences organization based in United States,
with around 174 employees and annual revenues of $69.6 million.
CytomX Therapeutics operates a diverse technology stack with applications such as
Oracle NetSuite ERP, Microsoft 365 and Agiloft Contract Lifecycle Management,
covering areas like ERP Financial, Collaboration and Contract Lifecycle Management.
CytomX Therapeutics has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Oracle, Microsoft and Agiloft.
CytomX Therapeutics recently adopted applications including
DocuSign eSignature in 2021, Google Cloud Platform (GCP) in 2021 and Okta Identity Cloud in 2021,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of CytomX Therapeutics’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates CytomX Therapeutics’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete CytomX Therapeutics technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.